drugset
drugset / Trial / NCT01645254

Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali

NCT01645254 ↗

Phase 1 Unknown 24 enrolled University of Bamako University of Geneva, Switzerland · collab
NaSingle-groupOpen-label

Summary

The main objective is to study the pharmacokinetics, pharmacodynamics and tolerability of the decoction of the aerial parts of Argemone mexicana (AM), administered in healthy volunteers.

Timeline

Start
2012-09
Primary completion
2012-10
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Argemone mexicana Traditional medicine (herbal / TCM) 30 g Oral

Indications

malaria